Henry Schein, Inc. (NASDAQ:HSIC) posted its quarterly earnings data on Tuesday, August 8th. The company reported $1.75 EPS for the quarter, beating the Zacks’ consensus estimate of $1.73 by $0.02, RTT News reports. Henry Schein had a net margin of 4.59% and a return on equity of 19.91%. The company had revenue of $3.06 billion during the quarter, compared to the consensus estimate of $3.05 billion. During the same quarter in the prior year, the company posted $1.64 EPS. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. Henry Schein updated its FY17 guidance to $7.17-7.30 EPS.
Shares of Henry Schein (HSIC) opened at 169.49 on Friday. The firm’s 50-day moving average price is $179.49 and its 200-day moving average price is $175.49. The firm has a market capitalization of $13.40 billion, a price-to-earnings ratio of 24.77 and a beta of 1.09. Henry Schein has a 12 month low of $146.23 and a 12 month high of $186.99. Shares of Henry Schein are going to split on the morning of Friday, September 15th. The 2-1 split was announced on Wednesday, August 16th. The newly issued shares will be payable to shareholders after the closing bell on Thursday, September 14th.
Several hedge funds and other institutional investors have recently bought and sold shares of HSIC. SpiderRock Advisors LLC acquired a new position in Henry Schein during the first quarter valued at $102,000. YorkBridge Wealth Partners LLC raised its position in Henry Schein by 5.2% in the second quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock valued at $104,000 after buying an additional 28 shares during the period. Sun Life Financial INC raised its position in Henry Schein by 8,185.7% in the second quarter. Sun Life Financial INC now owns 580 shares of the company’s stock valued at $106,000 after buying an additional 573 shares during the period. Lee Financial Co acquired a new position in Henry Schein during the second quarter valued at $161,000. Finally, Westside Investment Management Inc. acquired a new position in Henry Schein during the first quarter valued at $168,000. 90.60% of the stock is owned by hedge funds and other institutional investors.
A number of analysts recently issued reports on HSIC shares. Credit Suisse Group reiterated a “hold” rating and set a $160.00 target price on shares of Henry Schein in a research note on Thursday, July 13th. Stifel Nicolaus increased their target price on Henry Schein from $174.00 to $178.00 and gave the company a “hold” rating in a research note on Wednesday, May 10th. Zacks Investment Research upgraded Henry Schein from a “hold” rating to a “buy” rating and set a $204.00 target price for the company in a research note on Thursday, May 25th. Piper Jaffray Companies began coverage on Henry Schein in a research note on Monday, June 12th. They set a “neutral” rating and a $200.00 target price for the company. Finally, BidaskClub cut Henry Schein from a “hold” rating to a “sell” rating in a research note on Wednesday, August 2nd. One analyst has rated the stock with a sell rating, ten have issued a hold rating and seven have given a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $185.56.
Henry Schein Company Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.